文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

1 型糖尿病患儿发病时肠道微生物群的功能和分类特征:一项代谢蛋白质组学研究。

Functional and Taxonomic Traits of the Gut Microbiota in Type 1 Diabetes Children at the Onset: A Metaproteomic Study.

机构信息

Unit of Human Microbiome, Multimodal Laboratory Medicine Research Area, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

Diabetes & Growth Disorders Unit, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

出版信息

Int J Mol Sci. 2022 Dec 15;23(24):15982. doi: 10.3390/ijms232415982.


DOI:10.3390/ijms232415982
PMID:36555624
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9787575/
Abstract

Type 1 diabetes (T1D) is a chronic autoimmune metabolic disorder with onset in pediatric/adolescent age, characterized by insufficient insulin production, due to a progressive destruction of pancreatic β-cells. Evidence on the correlation between the human gut microbiota (GM) composition and T1D insurgence has been recently reported. In particular, 16S rRNA-based metagenomics has been intensively employed in the last decade in a number of investigations focused on GM representation in relation to a pre-disease state or to a response to clinical treatments. On the other hand, few works have been published using alternative functional omics, which is more suitable to provide a different interpretation of such a relationship. In this work, we pursued a comprehensive metaproteomic investigation on T1D children compared with a group of siblings (SIBL) and a reference control group (CTRL) composed of aged matched healthy subjects, with the aim of finding features in the T1D patients' GM to be related with the onset of the disease. Modulated metaproteins were found either by comparing T1D with CTRL and SIBL or by stratifying T1D by insulin need (IN), as a proxy of β-cells damage, showing some functional and taxonomic traits of the GM, possibly related to the disease onset at different stages of severity.

摘要

1 型糖尿病(T1D)是一种慢性自身免疫代谢紊乱疾病,发病于儿童/青少年时期,其特征是由于胰腺 β 细胞的进行性破坏,导致胰岛素产生不足。最近有证据表明,人类肠道微生物群(GM)组成与 T1D 发病之间存在相关性。特别是,在过去十年中,基于 16S rRNA 的宏基因组学已被广泛应用于多项研究中,这些研究集中于 GM 与疾病前状态或对临床治疗的反应之间的关系。另一方面,使用替代功能组学的研究较少,而后者更适合对这种关系提供不同的解释。在这项工作中,我们对 T1D 患儿进行了全面的宏蛋白质组学研究,与一组兄弟姐妹(SIBL)和由年龄匹配的健康受试者组成的参考对照组(CTRL)进行了比较,目的是在 T1D 患者的 GM 中找到与疾病发病相关的特征。通过比较 T1D 与 CTRL 和 SIBL,或者通过根据胰岛素需求(IN)对 T1D 进行分层(IN 是 β 细胞损伤的替代物),我们发现了一些被调节的宏蛋白质,这些蛋白质显示了 GM 的一些功能和分类特征,可能与疾病在不同严重程度阶段的发病有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403d/9787575/5bc872c02388/ijms-23-15982-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403d/9787575/af5d673843af/ijms-23-15982-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403d/9787575/e865cda95766/ijms-23-15982-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403d/9787575/2272783a9879/ijms-23-15982-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403d/9787575/5bc872c02388/ijms-23-15982-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403d/9787575/af5d673843af/ijms-23-15982-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403d/9787575/e865cda95766/ijms-23-15982-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403d/9787575/2272783a9879/ijms-23-15982-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403d/9787575/5bc872c02388/ijms-23-15982-g004.jpg

相似文献

[1]
Functional and Taxonomic Traits of the Gut Microbiota in Type 1 Diabetes Children at the Onset: A Metaproteomic Study.

Int J Mol Sci. 2022-12-15

[2]
Gut Microbiota Functional Traits, Blood pH, and Anti-GAD Antibodies Concur in the Clinical Characterization of T1D at Onset.

Int J Mol Sci. 2022-9-6

[3]
A metaproteomic-based gut microbiota profiling in children affected by autism spectrum disorders.

J Proteomics. 2022-1-16

[4]
Duodenal Mucosa of Patients With Type 1 Diabetes Shows Distinctive Inflammatory Profile and Microbiota.

J Clin Endocrinol Metab. 2017-5-1

[5]
Association between new onset type 1 diabetes and real-world antibiotics and neonicotinoids' exposure-related gut microbiota perturbation.

World J Pediatr. 2022-10

[6]
Gut Microbiota Profile in Patients with Type 1 Diabetes Based on 16S rRNA Gene Sequencing: A Systematic Review.

Dis Markers. 2020

[7]
Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study.

Diabetes Care. 2018-9-17

[8]
Clostridial Butyrate Biosynthesis Enzymes Are Significantly Depleted in the Gut Microbiota of Nonobese Diabetic Mice.

mSphere. 2018-10-24

[9]
The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis.

Front Endocrinol (Lausanne). 2020

[10]
Association between intestinal permeability and faecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetes.

Diabetes Metab Res Rev. 2016-10

引用本文的文献

[1]
Gut microbial metabolites targeting JUN in renal cell carcinoma via IL-17 signaling pathway: network pharmacology approach.

Mol Divers. 2025-4-18

[2]
Metaproteomics reveals diet-induced changes in gut microbiome function according to Crohn's disease location.

Microbiome. 2024-10-23

[3]
A novel clinical metaproteomics workflow enables bioinformatic analysis of host-microbe dynamics in disease.

mSphere. 2024-6-25

[4]
The metaproteome of the gut microbiota in pediatric patients affected by COVID-19.

Front Cell Infect Microbiol. 2023

[5]
Williams-Beuren syndrome shapes the gut microbiota metaproteome.

Sci Rep. 2023-11-3

[6]
Editorial of Special Issues "Gut Microbiota-Host Interactions: From Symbiosis to Dysbiosis 2.0".

Int J Mol Sci. 2023-5-19

[7]
Association between Gut Dysbiosis and the Occurrence of SIBO, LIBO, SIFO and IMO.

Microorganisms. 2023-2-24

[8]
Autoimmune diseases and gut microbiota: a bibliometric and visual analysis from 2004 to 2022.

Clin Exp Med. 2023-10

本文引用的文献

[1]
Gut Microbiota Functional Traits, Blood pH, and Anti-GAD Antibodies Concur in the Clinical Characterization of T1D at Onset.

Int J Mol Sci. 2022-9-6

[2]
Metaproteomics Approach and Pathway Modulation in Obesity and Diabetes: A Narrative Review.

Nutrients. 2021-12-23

[3]
The Role of the Gut Microbiota in the Pathogenesis of Diabetes.

Int J Mol Sci. 2022-1-1

[4]
Distinct Human Gut Microbial Taxonomic Signatures Uncovered With Different Sample Processing and Microbial Cell Disruption Methods for Metaproteomic Analysis.

Front Microbiol. 2021-7-5

[5]
Exocrine Pancreas Dysfunction in Type 1 Diabetes.

Endocr Pract. 2020-12

[6]
Survey of metaproteomics software tools for functional microbiome analysis.

PLoS One. 2020-11-10

[7]
Gut Microbiota in T1DM-Onset Pediatric Patients: Machine-Learning Algorithms to Classify Microorganisms as Disease Linked.

J Clin Endocrinol Metab. 2020-9-1

[8]
Mass Spectrometry Based-Proteomic Analysis of spp.: A Preliminary Study towards a New Diagnostic Tool.

Genes (Basel). 2020-6-24

[9]
Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms.

Front Endocrinol (Lausanne). 2020

[10]
Metaproteomics: A strategy to study the taxonomy and functionality of the gut microbiota.

J Proteomics. 2020-5-15

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索